Computational-based drug repurposing methods in COVID-19

COVID-19, as a newly emerging disease, has disrupted human’s different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process,...

Full description

Bibliographic Details
Main Author: Yosef Masoudi-Sobhanzadeh
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2020-07-01
Series:BioImpacts
Subjects:
Online Access:https://bi.tbzmed.ac.ir/PDF/bi-10-205.pdf
Description
Summary:COVID-19, as a newly emerging disease, has disrupted human’s different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process, drug repurposing approaches may yield to proper curing plans. However, there are some limitations in this field, which make the process a challenging one. This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19.
ISSN:2228-5660
2228-5652